Cargando…

Balancing benefits and risks in the era of biologics

Biologics are substances synthetized from biological sources used in the prevention and treatment of several diseases. Rheumatologists have many years of experience with biologics for the treatment of immune-mediated diseases and osteoporosis. Randomized clinical trials and postmarketing studies hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adami, Giovanni, Saag, Kenneth G., Chapurlat, Roland D., Guañabens, Nuria, Haugeberg, Glenn, Lems, Willem F., Matijevic, Radmila, Peel, Nicola, Poddubnyy, Denis, Geusens, Piet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820177/ https://www.ncbi.nlm.nih.gov/pubmed/31695755 http://dx.doi.org/10.1177/1759720X19883973

Ejemplares similares

Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis
por: Geusens, Piet, et al.
Publicado: (2008)

Osteoimmunology and osteoporosis
por: Geusens, Piet, et al.
Publicado: (2011)

Measuring metacarpal cortical bone by digital x-ray radiogrammetry: a step forward?
por: Geusens, Piet P, et al.
Publicado: (2009)

Progress in osteoporosis and fracture prevention: focus on postmenopausal women
por: Saag, Kenneth G, et al.
Publicado: (2009)

Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial
por: Saag, Kenneth G., et al.
Publicado: (2019)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids
por: Saag, Kenneth G., et al.
Publicado: (2022)

Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment
por: Geusens, Piet, et al.
Publicado: (2022)

OsteoRheumatology: a new discipline?
por: Favero, Marta, et al.
Publicado: (2015)

Assessment of Individual Fracture Risk: FRAX and Beyond
por: van den Bergh, Joop P. W., et al.
Publicado: (2010)

Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era
por: Haugeberg, Glenn, et al.
Publicado: (2020)

Calcium and vitamin D supplementation: state of the art for daily practice
por: van der Velde, Robert Y., et al.
Publicado: (2014)

Patients with osteoporosis: children of a lesser god
por: Adami, Giovanni, et al.
Publicado: (2023)

Osteopenia: A Diagnostic and Therapeutic Challenge
por: Lems, Willem F., et al.
Publicado: (2011)

Patient preference and acceptability of calcium plus vitamin D(3) supplementation: a randomised, open, cross-over trial
por: den Uyl, Debby, et al.
Publicado: (2009)

Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era
por: Haugeberg, Glenn, et al.
Publicado: (2014)

No deterioration in health-related quality of life in patients with axial spondyloarthritis followed for 5 years in ordinary outpatient clinics in the biological treatment era
por: Rohde, Gudrun, et al.
Publicado: (2019)

Feasibility of rigid 3D image registration of high-resolution peripheral quantitative computed tomography images of healing distal radius fractures
por: de Jong, Joost J. A., et al.
Publicado: (2017)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Geusens, Piet
Publicado: (2009)

The role of RANK ligand/OPG system in bone erosions in rheumatoid arthritis
por: Geusens, Piet
Publicado: (2012)

New insights into treatment of osteoporosis in postmenopausal women
por: Geusens, Piet
Publicado: (2015)

Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice
por: Adami, Giovanni, et al.
Publicado: (2019)

Fracture prevention in COPD patients; a clinical 5-step approach
por: Romme, Elisabeth APM, et al.
Publicado: (2015)

Balancing risks and benefits of artificial intelligence in the health sector
por: Goodman, Kenneth, et al.
Publicado: (2020)

Quarantining arriving travelers in the era of COVID-19: balancing the risk and benefits a learning experience from Bahrain
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
por: Chapurlat, Roland D
Publicado: (2009)

Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis
por: Poddubnyy, Denis
Publicado: (2020)

Managing Psoriatic Arthritis Patients Presenting with Axial Symptoms
por: Poddubnyy, Denis
Publicado: (2023)

Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks
por: Scarpignato, Carmelo, et al.
Publicado: (2015)

Interest of Bone Histomorphometry in Bone Pathophysiology Investigation: Foundation, Present, and Future
por: Chavassieux, Pascale, et al.
Publicado: (2022)

Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts
por: Thomas, T., et al.
Publicado: (2020)

Benefits of Neuropsychiatric Phenomics: Example of the 5-Lipoxygenase-Leptin-Alzheimer Connection
por: Manev, Hari, et al.
Publicado: (2010)

Balancing risk and benefit during coronavirus
por: Sehn, Laurie H.
Publicado: (2020)

Biologicals and bone loss
por: Lems, Willem F
Publicado: (2012)

Glucocorticoids: bad or safe for the bones?
por: Lems, Willem F
Publicado: (2015)

Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss
por: Hoff, Mari, et al.
Publicado: (2007)

Perceived effects of health status on sexual activity in women and men older than 50 years
por: Rohde, Gudrun, et al.
Publicado: (2014)

Mortality after Distal Radius Fracture in Men and Women Aged 50 Years and Older in Southern Norway
por: Øyen, Jannike, et al.
Publicado: (2014)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Masud, Tahir, et al.
Publicado: (2009)

Treatment of Axial Spondyloarthritis: What Does the Future Hold?
por: Poddubnyy, Denis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jqpe49onbh4nobvgo7tr3qdk9a